trending Market Intelligence /marketintelligence/en/news-insights/trending/x-7Xp_tMGBVnydmvHXyJRA2 content esgSubNav
In This List

Allergan completes $2.9B LifeCell acquisition


Banking Essentials Newsletter: 7th February Edition

Case Study

A Bank Outsources Data Gathering to Meet Basel III Regulations


Private Markets 360° | Episode 8: Powering the Global Private Markets (with Adam Kansler of S&P Global Market Intelligence)


Essential IR Insights Newsletter Fall - 2023

Allergan completes $2.9B LifeCell acquisition

Allergan PLC acquired LifeCell Corp. for approximately $2.9 billion in cash.

The acquisition adds LifeCell's portfolio of reconstruction and complex hernia surgery products to Allergan's existing portfolio of medical aesthetic products, breast implants and tissue expanders.

The merger will also give Allergan access to LifeCell's manufacturing and R&D operations in New Jersey.

Guggenheim Securities and Barclays served as financial advisors to Allergan, while Debevoise & Plimpton LLP were Allergan's lead legal counsel.